Pharma Tech

Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule

Sep 3, 2026, 8:54 AM

Read Full Article → Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule

Translate article text

Choose a language and wait for the translated text.

Biocytogen Pharmaceuticals has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.